Spots Global Cancer Trial Database for montanide isa 51 vg

Every month we try and update this database with for montanide isa 51 vg cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission	NCT01842139	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye...	basiliximab WT1 126-134 pep... Montanide ISA 5... poly ICLC laboratory biom...	18 Years - 85 Years	University of Chicago
Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery	NCT01748747	Recurrent Melan... Stage IIA Melan... Stage IIB Melan... Stage IIC Melan... Stage IIIA Mela... Stage IIIB Mela... Stage IIIC Mela... Stage IV Melano...	Montanide ISA 5... MART-1 antigen laboratory biom... Gag:267-274 pep... resiquimod	18 Years -	Mayo Clinic
Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission	NCT01842139	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye...	basiliximab WT1 126-134 pep... Montanide ISA 5... poly ICLC laboratory biom...	18 Years - 85 Years	University of Chicago
Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558	NCT01176461	Melanoma (Skin)	MART-1 NY-ESO-1 gp100:209-217(2... gp100:280-288(2... Montanide ISA 5... BMS-936558	16 Years -	H. Lee Moffitt Cancer Center and Research Institute
EMD 640 744 in Montanide ISA 51 VG Administered in Subjects With Advanced Solid Tumors	NCT01012102	Advanced Solid ...	EMD 640744 EMD 640744 EMD 640744 Montanide ISA 5... Montanide ISA 5... Montanide ISA 5...	18 Years -	Merck KGaA, Darmstadt, Germany
Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission	NCT01842139	Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye... Adult Acute Mye...	basiliximab WT1 126-134 pep... Montanide ISA 5... poly ICLC laboratory biom...	18 Years - 85 Years	University of Chicago
Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome	NCT00004918	Accelerated Pha... Adult Acute Mye... Chronic Phase C... Previously Trea... Refractory Anem... Refractory Anem... Relapsing Chron...	PR1 leukemia pe... Montanide ISA 5... sargramostim laboratory biom...	19 Years -	National Cancer Institute (NCI)
Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma	NCT00019682	Recurrent Melan... Stage IIIA Skin... Stage IIIB Skin... Stage IIIC Skin... Stage IV Skin M...	Aldesleukin gp100 Antigen Montanide ISA 5... Quality-of-Life... Questionnaire A... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: